At close: 3:30:02 PM GMT+5:30
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 3 | 3 |
| Avg. Estimate | 0 | 0 | 1.09 | 1.52 |
| Low Estimate | 0 | 0 | 0.9 | 1.4 |
| High Estimate | 0 | 0 | 1.46 | 1.76 |
| Year Ago EPS | -- | -- | -- | 1.09 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 3 | 3 |
| Avg. Estimate | -- | -- | 54.67B | 62.35B |
| Low Estimate | -- | -- | 54.31B | 61.62B |
| High Estimate | -- | -- | 55B | 63.1B |
| Year Ago Sales | -- | -- | -- | 54.67B |
| Sales Growth (year/est) | -- | -- | -- | 14.06% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 1.09 | 1.52 |
| 7 Days Ago | 0 | 0 | 1.19 | 1.58 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SAGILITY.NS | -- | -- | -- | 39.71% |
| S&P 500 | 8.70% | 11.55% | 14.03% | 13.42% |
Related Tickers
IKS.NS INVENTURUS KNOWLEDGE SO L
1,914.35
-2.03%
INDGN.NS INDEGENE LIMITED
614.90
-2.25%
INDGN.BO Indegene Limited
615.05
-2.19%
IKS.BO INVENTURUS KNOWLEDGE SOLUTIONS
1,914.40
-2.00%
CERT Certara, Inc.
10.65
-3.36%
TXG 10x Genomics, Inc.
15.43
-2.53%
GDRX GoodRx Holdings, Inc.
4.4850
+4.79%
ACON Aclarion, Inc.
0.1270
-8.24%
TEM Tempus AI, Inc
37.51
+0.05%